Epidemiology of Parkinsons disease

Improving economy and health in countries like USA, Germany, has increased the life span and changed the emphasis from communicable to non-communicable diseases. It is expected that the prevalence of Parkinson’s disease in the 7MM (US, France, Italy, Spain, Germany, Brazil, and Japan) and UK will increase from 3.2m people in 2012 to 4.3m people in 2022. The global treatment for syndromes of the movement disorders market is anticipated to grow from an estimated $ 12,859.8 million in 2014 to $ 21,154.8 million in 2020 at a CAGR of 8.6% during the forecast period. This increase the prevalence of age-related diseases and movement disorders like Parkinson's disease (PD). We review epidemiological studies to describe: a) Developments in interdisciplinary of Parkinson and movement disorders, b) Aggregation and Protein Misfolding and c) potential of epidemiological research in countries with multiple ethnic races and environmental risks for PD, d) methodological issues, e) Prevalence of movement disorders.

The Parkinson's disease is the second most typical neurodegenerative disorder, are still mostly unknown. Current thinking is that major gene mutations cause only a small proportion of all cases which in most cases, non-genetic factors play vicinity, in all probability in interaction with susceptibility genes. Various epidemiologic studies have been done to spot such non-genetic risk factors, however most were tiny and methodologically restricted. Larger, well-designed prospective cohort studies have only recently reached a stage at that they need enough incident patients and person-years of follow-up to investigate possible risk factors and their interactions. We have a tendency to review what's familiar regarding the prevalence, incidence, risk factors, and prognosis of Parkinson's disease from epidemiologic studies.

  • Etiology of Parkinsons disease
  • Protein Misfolding & Aggregation
  • Developments in interdisciplinary of Parkinson disease
  • Interdisciplinary care in Parkinsons and other movement disorders

Related Conference of Epidemiology of Parkinsons disease

October 12-14, 2017

24th International Conference on Psychiatry & Psychosomatic Medicine

Park Inn by Radisson, London, UK
October 16-17, 2017

17th Global Neuroscience Conference

Osaka, Japan
November 20-21, 2017

28th International Conference on Psychiatry & Mental Health

Melbourne, Australia
February 22-23, 2018

10th International Conference on Vascular Dementia

Paris, France
June 14-16, 2018

25th World Congress on Neurology & Neuroscience

Amsterdam, Netherlands

November 5-6, 2018

World Summit on Spine and Spinal Disorders

San Franciso, USA
July 16-17, 2018

25th World Congress on Neurology and Neurodisorders

Melbourne, Australia
August 06-08, 2018

26th European Neurology Congress

Madrid, Spain
September 17-18, 2018

International Conference on Nervous System and Nerve Diseases

Philadelphia , USA
August 29-30, 2018

4th World Congress on Parkinsons & Huntington Disease

Zurich, Switzerland
August 29-30, 2018

4th International Conference on Epilepsy & Treatment

Zurich, Switzerland
September 13-14, 2018

7th International Conference on Neurological Disorders & Stroke

Prague, Czech Republic
September 13-14, 2018

4th International Conference on Spine and Spinal Disorders

Prague, Czech Republic
September 17-18, 2018

4th World Congress on Epilepsy and Treatment

Bali, Indonesia
September, 20-22

International Conference on Neurology & Health Care

Lisbon, Portugal
November 5-6, 2018

5th International Conference on Spine and Spinal Disorders

San Franciso, USA

Epidemiology of Parkinsons disease Conference Speakers